 NEW HAVEN, Conn., April 26, 2022 GLOBE NEWSWIRE -- Specialty cancer diagnostics company Precipio, Inc. NASDAQ: PRPO , is excited to announce its participation and the presentation of HemeScreen, its novel diagnostic technology platform, at the Executive War College , organized by publication Dark Daily, the premier laboratory conference, held April 26th through 28th in New Orleans. 